Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Citing competition, rebate concerns, AMA urges block of CVS-Aetna deal

The American Medical Association (AMA) has urged the U.S. Department of Justice to block the planned $69 billion merger between CVS Health and Aetna.

Insurer monopolies lead to higher health insurance premiums

Healthcare premiums have been rising rapidly over the past two years, but not all markets are seeing the same rates of inflation. Areas with fewer insurers are reporting higher premiums than other markets, according to a recent study published in Health Affairs.

Thumbnail

CMS proposes risk adjustment payments for 2018

After halting, then restarting, payments for the healthcare insurance risk-adjustment program, CMS has proposed keeping the payments for the 2018 benefits rule.

Thumbnail

Cigna strikes back against Carl Icahn over Express Scripts deal

Cigna executives are moving ahead with the planned acquisition of Express Scripts—despite objections by activist investor Carl Icahn.

Thumbnail

Tenet Healthcare shares drop 15% following earnings report

Tenet Healthcare, a Dallas-based healthcare services company, is struggling to offload its business services subsidiary, Conifer Health Solutions.

Thumbnail

Carl Icahn slams Express Scripts deal in public letter to Cigna

Investor Carl Icahn penned a public letter to shareholders of health insurance company Cigna in an effort to derail the acquisition of Express Scripts, a pharmacy benefits manager, for more than $60 billion.

Thumbnail

Healthcare continues to consolidate—and it isn’t helping patients

With several recent billion-dollar deals bringing together payers and providers, the U.S. healthcare market is consolidating—but the rising concentration isn’t improving quality of care or helping lower costs.

Thumbnail

FDA issues new guidelines to treat opioid use disorder

The U.S. FDA issued new draft guidelines to treat opioid use disorders that include using medication-assisted treatment drugs.

Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?